소장자료
| LDR | 04468cam a2200397 a 4500 | ||
| 001 | 0091886942▲ | ||
| 005 | 20180521061100▲ | ||
| 008 | 111012s2010 sz a 000 0 eng d▲ | ||
| 010 | ▼a2011409355▲ | ||
| 020 | ▼a9789241548069▲ | ||
| 020 | ▼a9241548061▲ | ||
| 035 | ▼a(KERIS)REF000016528123▲ | ||
| 040 | ▼aIXA▼cIXA▼dCUX▼dYDXCP▼dBWX▼dDLC▼d221016▲ | ||
| 042 | ▼alccopycat▲ | ||
| 050 | 0 | 0 | ▼aRA790.5▼bW49 2010▲ |
| 082 | 0 | 4 | ▼a362.2▼221▲ |
| 090 | ▼a362.2▼bW927mB▲ | ||
| 110 | 2 | ▼aWorld Health Organization.▼bMental Health Gap Action Programme.▲ | |
| 245 | 1 | 0 | ▼amhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings :▼bversion 1.0 /▼cMental Health Gap Action Programme, World Health Organization.▲ |
| 246 | 3 | ▼aMental Health Gap Action Programme intervention guide▲ | |
| 246 | 3 | ▼amhGAP intervention guide▲ | |
| 246 | 3 | ▼amhGAP-IG▲ | |
| 260 | ▼aGeneva :▼bWorld Health Organization,▼cc2010.▲ | ||
| 300 | ▼avii, 83 p. :▼bill. ;▼c30 cm. +▼e1 Chart▲ | ||
| 505 | 0 | ▼aI. Introduction -- -- II. General principles of care -- -- III. Master chart -- -- IV. Modules -- 1. Moderate-severe depression -- 2. Psychosis -- 3. Bipolar disorder -- 4. Epilepsy / seizures -- 5. Developmental disorders -- 6. Behavioural disorders -- 7. Dementia -- 8. Alcohol use and alcohol use disorders -- 9. Drug use and drug use disorders -- 10. Self-harm / suicide -- 11. Other significant emotional or medically unexplained complaints -- -- V. Advanced psychosocial interventions▲ | |
| 520 | ▼a"The mhGAP-IG has been developed through an intensive process of evidence review. Systematic reviews were conducted to develop evidence-based recommendations. The process involved a WHO Guideline Development Group of international experts, who collaborated closely with the WHO Secretariat. The recommendations were then converted into clearly presented stepwise interventions, again with the collaboration of an international group of experts. The mhGAP-IG was then circulated among a wider range of reviewers across the world to include all the diverse contributions. The mhGAP-IG is based on the mhGAP Guidelines on interventions for mental, neurological and substance use disorders. The mhGAP Guidelines and the mhGAP-IG will be reviewed and updated in 5 years. Any revision and update before that will be made to the online version of the document. The mhGAP-IG has been developed for use in non-specialized health-care settings. It is aimed at health-care providers working at first- and second-level facilities. These health-care providers may be working in a health centre or as part of the clinical team at a district-level hospital or clinic. They include general physicians, family physicians, nurses and clinical officers. Other non-specialist health-care providers can use the mhGAP-IG with necessary adaptation. The first-level facilities include the health-care centres that serve as first point of contact with a health professional and provide outpatient medical and nursing care. Services are provided by general practitioners or physicians, dentists, clinical officers, community nurses, pharmacists and midwives, among others. Second-level facilities include the hospital at the first referral level responsible for a district or a defined geographical area containing a defined population and governed by a politico-administrative organization, such as a district health management team. The district clinician or mental health specialist supports the firstlevel health-care team for mentoring and referral. The mhGAP-IG is brief so as to facilitate interventions by busy non-specialists in low- and middle-income countries. It describes in detail what to do but does not go into descriptions of how to do. It is important that the non-specialist health-care providers are trained and then supervised and supported in using the mhGAP-IG in assessing and managing people with mental, neurological and substance use disorders." - p. 2▲ | ||
| 650 | 0 | ▼aMental illness▼xPrevention.▲ | |
| 650 | 0 | ▼aSubstance abuse.▲ | |
| 650 | 1 | 2 | ▼aMental Disorders▼xdiagnosis▼vHandbooks.▲ |
| 650 | 1 | 2 | ▼aNervous System Diseases▼xdiagnosis▼vHandbooks.▲ |
| 650 | 1 | 2 | ▼aSubstance-Related Disorders▼xdiagnosis▼vHandbooks.▲ |
| 650 | 2 | 2 | ▼aMental Disorders▼xtherapy▼vHandbooks.▲ |
| 650 | 2 | 2 | ▼aNervous System Diseases▼xtherapy▼vHandbooks.▲ |
| 650 | 2 | 2 | ▼aSubstance-Related Disorders▼xtherapy▼vHandbooks.▲ |
| 710 | 2 | ▼aWorld Health Organization.▲ | |
| 999 | ▼a정영주▼c정영주▲ |
mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings :version 1.0
자료유형
국외단행본
서명/책임사항
mhGAP intervention guide for mental, neurological and substance use disorders in non-specialized health settings : version 1.0 / Mental Health Gap Action Programme, World Health Organization.
다양한 서명
Mental Health Gap Action Programme intervention guide
mhGAP intervention guide
mhGAP-IG
mhGAP intervention guide
mhGAP-IG
발행사항
Geneva : World Health Organization , c2010.
형태사항
vii, 83 p. : ill. ; 30 cm. + 1 Chart
내용주기
I. Introduction -- -- II. General principles of care -- -- III. Master chart -- -- IV. Modules -- 1. Moderate-severe depression -- 2. Psychosis -- 3. Bipolar disorder -- 4. Epilepsy / seizures -- 5. Developmental disorders -- 6. Behavioural disorders -- 7. Dementia -- 8. Alcohol use and alcohol use disorders -- 9. Drug use and drug use disorders -- 10. Self-harm / suicide -- 11. Other significant emotional or medically unexplained complaints -- -- V. Advanced psychosocial interventions
요약주기
"The mhGAP-IG has been developed through an intensive process of evidence review. Systematic reviews were conducted to develop evidence-based recommendations. The process involved a WHO Guideline Development Group of international experts, who collaborated closely with the WHO Secretariat. The recommendations were then converted into clearly presented stepwise interventions, again with the collaboration of an international group of experts. The mhGAP-IG was then circulated among a wider range of reviewers across the world to include all the diverse contributions. The mhGAP-IG is based on the mhGAP Guidelines on interventions for mental, neurological and substance use disorders. The mhGAP Guidelines and the mhGAP-IG will be reviewed and updated in 5 years. Any revision and update before that will be made to the online version of the document. The mhGAP-IG has been developed for use in non-specialized health-care settings. It is aimed at health-care providers working at first- and second-level facilities. These health-care providers may be working in a health centre or as part of the clinical team at a district-level hospital or clinic. They include general physicians, family physicians, nurses and clinical officers. Other non-specialist health-care providers can use the mhGAP-IG with necessary adaptation. The first-level facilities include the health-care centres that serve as first point of contact with a health professional and provide outpatient medical and nursing care. Services are provided by general practitioners or physicians, dentists, clinical officers, community nurses, pharmacists and midwives, among others. Second-level facilities include the hospital at the first referral level responsible for a district or a defined geographical area containing a defined population and governed by a politico-administrative organization, such as a district health management team. The district clinician or mental health specialist supports the firstlevel health-care team for mentoring and referral. The mhGAP-IG is brief so as to facilitate interventions by busy non-specialists in low- and middle-income countries. It describes in detail what to do but does not go into descriptions of how to do. It is important that the non-specialist health-care providers are trained and then supervised and supported in using the mhGAP-IG in assessing and managing people with mental, neurological and substance use disorders." - p. 2
주제
Mental illness, Prevention.
Substance abuse.
Mental Disorders, diagnosis, Handbooks.
Nervous System Diseases, diagnosis, Handbooks.
Substance-Related Disorders, diagnosis, Handbooks.
Mental Disorders, therapy, Handbooks.
Nervous System Diseases, therapy, Handbooks.
Substance-Related Disorders, therapy, Handbooks.
Substance abuse.
Mental Disorders, diagnosis, Handbooks.
Nervous System Diseases, diagnosis, Handbooks.
Substance-Related Disorders, diagnosis, Handbooks.
Mental Disorders, therapy, Handbooks.
Nervous System Diseases, therapy, Handbooks.
Substance-Related Disorders, therapy, Handbooks.
ISBN
9789241548069 9241548061
청구기호
362.2 W927mB
소장정보
예도서예약
서서가에없는책 신고
방방문대출신청
보보존서고신청
캠캠퍼스대출
우우선정리신청
배자료배달신청
문문자발송
출청구기호출력
학소장학술지 원문서비스
| 등록번호 | 청구기호 | 소장처 | 도서상태 | 반납예정일 | 서비스 |
|---|
북토크
자유롭게 책을 읽고
느낀점을 적어주세요
글쓰기
느낀점을 적어주세요
청구기호 브라우징
관련 인기대출 도서